Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective CohortAsim V. Farooq, Kashif Asghar|OncoTargets and Therapy|2025Cited by 1